BioLineRx Ltd (BLRX) Return on equity 2024–2025
BioLineRx Ltd (BLRX) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-11.1%FY2025 · since FY2024: -68.5% → -11.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -11.1% | +57.4 pp |
| FY2024 | -68.5% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More BLRX financial trends
BLRX RevenueBLRX Net incomeBLRX Net marginBLRX Gross profitBLRX Gross marginBLRX Operating incomeBLRX Operating marginBLRX Operating cash flowBLRX Free cash flowBLRX Capital expendituresBLRX Stock buybacksBLRX Dividends paidBLRX Total assetsBLRX Total liabilitiesBLRX Shareholders’ equityBLRX overview →